<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Nature Biotechnology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Nature Biotechnology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Nature+Biotechnology&t=Nature+Biotechnology&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 18:15:15 +0100</lastBuildDate>
        <item>
            <title>People</title>
            <link>http://www.medworm.com/index.php?rid=5674079&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FuVif1dQGnP8%2Fnbt.2124</link>
            <description>Nature Biotechnology 30, 196 (2012). 
      doi:10.1038/nbt.2124 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674079</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674079</guid>        </item>
        <item>
            <title>Fourth-quarter biotech job picture</title>
            <link>http://www.medworm.com/index.php?rid=5674078&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FI8yPdxzt2rw%2Fnbt.2123</link>
            <description>Nature Biotechnology 30, 195 (2012). 
      doi:10.1038/nbt.2123

Author: Michael Francisco (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674078</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674078</guid>        </item>
        <item>
            <title>Corrigendum: Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India</title>
            <link>http://www.medworm.com/index.php?rid=5674077&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FzvadUHENlNE%2Fnbt0212-193f</link>
            <description>Authors: Swathi Padmanabhan, Tahir Amin, Bhaven Sampat, Robert Cook-Deegan &amp; Subhashini Chandrasekharan (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674077</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674077</guid>        </item>
        <item>
            <title>Corrigendum: Chinese vaccine developers gain WHO imprimatur</title>
            <link>http://www.medworm.com/index.php?rid=5674076&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FSfkxMZD1K0Y%2Fnbt0212-193e</link>
            <description>Authors: Hepeng Jia &amp; Karen Carey (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674076</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674076</guid>        </item>
        <item>
            <title>Corrigendum: FDA panel votes to pull Avastin in breast cancer, again</title>
            <link>http://www.medworm.com/index.php?rid=5674075&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F4R_PesGDpkU%2Fnbt0212-193d</link>
            <description>Nature Biotechnology 30, 193 (2012). 
      doi:10.1038/nbt0212-193d

Author: Mark Ratner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674075</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674075</guid>        </item>
        <item>
            <title>Corrigendum: Industry continues dabbling with open innovation models</title>
            <link>http://www.medworm.com/index.php?rid=5674074&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FkTjj0FGHTvQ%2Fnbt0212-193c</link>
            <description>Nature Biotechnology 30, 193 (2012). 
      doi:10.1038/nbt0212-193c

Author: Cormac Sheridan (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674074</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674074</guid>        </item>
        <item>
            <title>Erratum: Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction</title>
            <link>http://www.medworm.com/index.php?rid=5674073&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fw6h5mG7NW8I%2Fnbt0212-193b</link>
            <description>Authors: Guo-Yun Chen, Xi Chen, Samantha King, Karen A Cavassani, Jiansong Cheng, Xincheng Zheng, Hongzhi Cao, Hai Yu, Jingyao Qu, Dexing Fang, Wei Wu, Xue-Feng Bai, Jin-Qing Liu, Shireen A Woodiga, Chong Chen, Lei Sun, Cory M Hogaboam, Steven L Kunkel, Pan Zheng &amp; Yang Liu (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674073</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674073</guid>        </item>
        <item>
            <title>Erratum: Factors influencing agbiotech adoption and development in sub-Saharan Africa</title>
            <link>http://www.medworm.com/index.php?rid=5674072&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FXVUt4niNHs4%2Fnbt0212-193a</link>
            <description>Authors: Obidimma C Ezezika, Abdallah S Daar, Kathryn Barber, Justin Mabeya, Fiona Thomas, Jennifer Deadman, Debbie Wang &amp; Peter A Singer (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674072</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674072</guid>        </item>
        <item>
            <title>Drug partners for antibiotics</title>
            <link>http://www.medworm.com/index.php?rid=5674065&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fh9Y0SGeM364%2Fnbt.2131</link>
            <description>Nature Biotechnology 30, 158 (2012). 
      doi:10.1038/nbt.2131

Author: Jason Kreisberg (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674065</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674065</guid>        </item>
        <item>
            <title>Mapping chromatin regulators</title>
            <link>http://www.medworm.com/index.php?rid=5674064&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fn3HFezDywg8%2Fnbt.2130</link>
            <description>Nature Biotechnology 30, 158 (2012). 
      doi:10.1038/nbt.2130

Author: Markus Elsner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674064</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674064</guid>        </item>
        <item>
            <title>Improving glycoconjugate vaccines</title>
            <link>http://www.medworm.com/index.php?rid=5674063&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FsDBcbyM6j1c%2Fnbt.2129</link>
            <description>Nature Biotechnology 30, 158 (2012). 
      doi:10.1038/nbt.2129

Author: Susan Jones (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674063</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674063</guid>        </item>
        <item>
            <title>True colors of genome variation</title>
            <link>http://www.medworm.com/index.php?rid=5674062&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FAPAVilK_62c%2Fnbt.2128</link>
            <description>Nature Biotechnology 30, 158 (2012). 
      doi:10.1038/nbt.2128

Author: Susan Jones (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674062</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674062</guid>        </item>
        <item>
            <title>TAL effector–DNA structure</title>
            <link>http://www.medworm.com/index.php?rid=5674061&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FYHaJxL-FMDs%2Fnbt.2127</link>
            <description>TAL effector&amp;#8211;DNA structure

Nature Biotechnology 30, 158 (2012). 
      doi:10.1038/nbt.2127

Author: Laura DeFrancesco (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674061</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674061</guid>        </item>
        <item>
            <title>Gene-based passive antibody protection from HIV</title>
            <link>http://www.medworm.com/index.php?rid=5674060&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FfwETH_eAd6I%2Fnbt.2114</link>
            <description>Nature Biotechnology 30, 156 (2012). 
      doi:10.1038/nbt.2114

Author: Margaret A Liu
Optimized AAV vectors encoding broadly neutralizing antibodies against HIV show promise in mice. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674060</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674060</guid>        </item>
        <item>
            <title>Complex binding sites made to order</title>
            <link>http://www.medworm.com/index.php?rid=5674059&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FhMt0RUfJSmk%2Fnbt.2118</link>
            <description>Authors: Jamie K Scott, Ralph Pantophlet &amp; Lisa Craig
A new computational strategy facilitates de novo design of discontinuous epitopes on protein scaffolds. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674059</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674059</guid>        </item>
        <item>
            <title>Smooth muscle diversity from human pluripotent cells</title>
            <link>http://www.medworm.com/index.php?rid=5674058&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FRqF3v3ifPCY%2Fnbt.2117</link>
            <description>Authors: Mark W Majesky &amp; Christine L Mummery
A method for differentiating human pluripotent stem cells into several subtypes of smooth muscle cell should aid the study and treatment of vascular disease. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674058</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674058</guid>        </item>
        <item>
            <title>Recent patent applications related to stem cells</title>
            <link>http://www.medworm.com/index.php?rid=5674057&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F6wJGXoRF2EE%2Fnbt.2125</link>
            <description>Nature Biotechnology 30, 151 (2012). 
      doi:10.1038/nbt.2125 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674057</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674057</guid>        </item>
        <item>
            <title>Funding and performance at the US Patent and Trademark Office</title>
            <link>http://www.medworm.com/index.php?rid=5674056&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FKsKrqCV0loY%2Fnbt.2110</link>
            <description>Nature Biotechnology 30, 148 (2012). 
      doi:10.1038/nbt.2110

Author: Deepak Hegde (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674056</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674056</guid>        </item>
        <item>
            <title>Personal medicine—the new banking crisis</title>
            <link>http://www.medworm.com/index.php?rid=5674055&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FZEF_mInhW6o%2Fnbt.2116</link>
            <description>Personal medicine&amp;#8212;the new banking crisis

Nature Biotechnology 30, 141 (2012). 
      doi:10.1038/nbt.2116

Authors: Christopher Thomas Scott, Timothy Caulfield, Emily Borgelt &amp; Judy Illes (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674055</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674055</guid>        </item>
        <item>
            <title>The blinded buyer</title>
            <link>http://www.medworm.com/index.php?rid=5674054&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FWY__EhC-mNg%2Fnbt.2094</link>
            <description>Nature Biotechnology 30, 139 (2012). 
      doi:10.1038/nbt.2094

Author: Brady Huggett (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674054</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674054</guid>        </item>
        <item>
            <title>OpenVigil—free eyeballs on AERS pharmacovigilance data</title>
            <link>http://www.medworm.com/index.php?rid=5674053&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FfQKnyuSkK_w%2Fnbt.2113</link>
            <description>OpenVigil&amp;#8212;free eyeballs on AERS pharmacovigilance data

Nature Biotechnology 30, 137 (2012). 
      doi:10.1038/nbt.2113

Authors: Ruwen B&amp;#246;hm, Jan H&amp;#246;cker, Ingolf Cascorbi &amp; Thomas Herdegen (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674053</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674053</guid>        </item>
        <item>
            <title>PRIDE Inspector: a tool to visualize and validate MS proteomics data</title>
            <link>http://www.medworm.com/index.php?rid=5674052&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FS004FlBl_jY%2Fnbt.2112</link>
            <description>Authors: Rui Wang, Antonio Fabregat, Daniel R&amp;#237;os, David Ovelleiro, Joseph M Foster, Richard G C&amp;#244;t&amp;#233;, Johannes Griss, Attila Csordas, Yasset Perez-Riverol, Florian Reisinger, Henning Hermjakob, Lennart Martens &amp; Juan Antonio Vizca&amp;#237;no (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674052</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674052</guid>        </item>
        <item>
            <title>Planning for the exit</title>
            <link>http://www.medworm.com/index.php?rid=5674051&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fhj51jdg1vzc%2Fnbt.2093</link>
            <description>Nature Biotechnology 30, 132 (2012). 
      doi:10.1038/nbt.2093

Author: Kenneth E Eheman (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674051</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674051</guid>        </item>
        <item>
            <title>Fresh from the pipeline 2011</title>
            <link>http://www.medworm.com/index.php?rid=5674050&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FZLFx8GjyEeo%2Fnbt.2111</link>
            <description>Nature Biotechnology 30, 128 (2012). 
      doi:10.1038/nbt.2111

Author: Jim Kling (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674050</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674050</guid>        </item>
        <item>
            <title>2011—Big biotechs gorge on debt</title>
            <link>http://www.medworm.com/index.php?rid=5674049&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FxyPSV-uycD0%2Fnbt.2119</link>
            <description>2011&amp;#8212;Big biotechs gorge on debt

Nature Biotechnology 30, 127 (2012). 
      doi:10.1038/nbt.2119

Author: Walter Yang (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674049</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674049</guid>        </item>
        <item>
            <title>Around the world in a month</title>
            <link>http://www.medworm.com/index.php?rid=5674048&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FPS6nP0nJX9o%2Fnbt0212-126b</link>
            <description>Nature Biotechnology 30, 126 (2012). 
      doi:10.1038/nbt0212-126b (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674048</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674048</guid>        </item>
        <item>
            <title>Life Technologies promises $1,000 genome</title>
            <link>http://www.medworm.com/index.php?rid=5674047&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FJKg2RoaOEJM%2Fnbt0212-126a</link>
            <description>Life Technologies promises &amp;#36;1,000 genome

Nature Biotechnology 30, 126 (2012). 
      doi:10.1038/nbt0212-126a

Author: Laura DeFrancesco (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674047</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674047</guid>        </item>
        <item>
            <title>UK government unveils innovation booster</title>
            <link>http://www.medworm.com/index.php?rid=5674046&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FXDLJ-do1t0Q%2Fnbt0212-125</link>
            <description>Nature Biotechnology 30, 125 (2012). 
      doi:10.1038/nbt0212-125

Author: Nuala Moran (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674046</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674046</guid>        </item>
        <item>
            <title>Toll-like receptor blocker slows beta cell death in type 1 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5674045&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FKsL6N7vu9fQ%2Fnbt0212-124c</link>
            <description>Nature Biotechnology 30, 124 (2012). 
      doi:10.1038/nbt0212-124c

Author: Susan Aldridge (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674045</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674045</guid>        </item>
        <item>
            <title>India's innovation czar</title>
            <link>http://www.medworm.com/index.php?rid=5674044&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FWVfdgURdbyE%2Fnbt0212-124b</link>
            <description>Nature Biotechnology 30, 124 (2012). 
      doi:10.1038/nbt0212-124b

Author: Killugudi Jayaraman (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674044</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674044</guid>        </item>
        <item>
            <title>Ablynx drops lead nanobody</title>
            <link>http://www.medworm.com/index.php?rid=5674043&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FkMnuxjkTWGo%2Fnbt0212-124a</link>
            <description>Nature Biotechnology 30, 124 (2012). 
      doi:10.1038/nbt0212-124a

Author: Gunjan Sinha (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674043</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674043</guid>        </item>
        <item>
            <title>Enbrel patent surfaces</title>
            <link>http://www.medworm.com/index.php?rid=5674042&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FQCbGljrC6Fc%2Fnbt0212-123</link>
            <description>Nature Biotechnology 30, 123 (2012). 
      doi:10.1038/nbt0212-123

Author: Charlotte Harrison (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674042</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674042</guid>        </item>
        <item>
            <title>Affymetrix sued for fraud</title>
            <link>http://www.medworm.com/index.php?rid=5674041&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F1qvPs0L2UhI%2Fnbt0212-122b</link>
            <description>Nature Biotechnology 30, 122 (2012). 
      doi:10.1038/nbt0212-122b

Author: Jennifer Rohn (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674041</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674041</guid>        </item>
        <item>
            <title>Gilead's $11 billion HCV bet</title>
            <link>http://www.medworm.com/index.php?rid=5674040&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FjYj0wuAe1_A%2Fnbt0212-122a</link>
            <description>Gilead's &amp;#36;11 billion HCV bet

Nature Biotechnology 30, 122 (2012). 
      doi:10.1038/nbt0212-122a

Author: Karen Carey (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674040</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674040</guid>        </item>
        <item>
            <title>Sangamo's lead zinc-finger therapy flops in diabetic neuropathy</title>
            <link>http://www.medworm.com/index.php?rid=5674039&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FhHx-1ntqHPQ%2Fnbt0212-121a</link>
            <description>Nature Biotechnology 30, 121 (2012). 
      doi:10.1038/nbt0212-121a

Author: Michael Eisenstein (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674039</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674039</guid>        </item>
        <item>
            <title>Amyloid disease drug approved</title>
            <link>http://www.medworm.com/index.php?rid=5674038&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FNCAT0GQq1b8%2Fnbt0212-121b</link>
            <description>Nature Biotechnology 30, 121 (2012). 
      doi:10.1038/nbt0212-121b

Author: Ken Garber (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674038</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674038</guid>        </item>
        <item>
            <title>Big pharma upheavals cast shadow across biotech sector</title>
            <link>http://www.medworm.com/index.php?rid=5674037&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FXoVVJlCVYk8%2Fnbt0212-119</link>
            <description>Nature Biotechnology 30, 119 (2012). 
      doi:10.1038/nbt0212-119

Author: Mark Ratner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674037</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674037</guid>        </item>
        <item>
            <title>Why genies don't go back into bottles</title>
            <link>http://www.medworm.com/index.php?rid=5674036&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FegVKIh8yXkM%2Fnbt.2133</link>
            <description>Nature Biotechnology 30, 117 (2012). 
      doi:10.1038/nbt.2133 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674036</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674036</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=5674035&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FZ50gyvzrxCI%2Fnbt.2132</link>
            <description>Nature Biotechnology 30, vii (2012). 
      doi:10.1038/nbt.2132 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674035</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674035</guid>        </item>
        <item>
            <title>Increased Diels-Alderase activity through backbone remodeling guided by Foldit players</title>
            <link>http://www.medworm.com/index.php?rid=5674071&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FCB18GqzBmnU%2Fnbt.2109</link>
            <description>Authors: Christopher B Eiben, Justin B Siegel, Jacob B Bale, Seth Cooper, Firas Khatib, Betty W Shen, Foldit Players, Barry L Stoddard, Zoran Popovic &amp; David Baker
Computational enzyme design holds promise for the production of renewable fuels, drugs and chemicals. De novo enzyme design has generated catalysts for several reactions, but with lower catalytic efficiencies than naturally occurring enzymes. Here we report the use of game-driven crowdsourcing to enhance the activity of a computationally designed enzyme through the functional remodeling of its structure. Players of the online game Foldit were challenged to remodel the backbone of a computationally designed bimolecular Diels-Alderase to enable additional interactions with substrates. Several iterations of design and character...</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674071</comments>
            <pubDate>Sun, 22 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674071</guid>        </item>
        <item>
            <title>Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates</title>
            <link>http://www.medworm.com/index.php?rid=5674070&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FwS3drYTVuuk%2Fnbt.2108</link>
            <description>Authors: Ben-Quan Shen, Keyang Xu, Luna Liu, Helga Raab, Sunil Bhakta, Margaret Kenrick, Kathryn L Parsons-Reponte, Janet Tien, Shang-Fan Yu, Elaine Mai, Dongwei Li, Jay Tibbitts, Jakub Baudys, Ola M Saad, Suzie J Scales, Paul J McDonald, Philip E Hass, Charles Eigenbrot, Trung Nguyen, Willy A Solis, Reina N Fuji, Kelly M Flagella, Darshana Patel, Susan D Spencer, Leslie A Khawli, Allen Ebens, Wai Lee Wong, Richard Vandlen, Surinder Kaur, Mark X Sliwkowski, Richard H Scheller, Paul Polakis &amp; Jagath R Junutula
The reactive thiol in cysteine is used for coupling maleimide linkers in the generation of antibody conjugates. To assess the impact of the conjugation site, we engineered cysteines into a therapeutic HER2/neu antibody at three sites differing in solvent accessibility and local ch...</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674070</comments>
            <pubDate>Sun, 22 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674070</guid>        </item>
        <item>
            <title>Genome sequencing reveals agronomically important loci in rice using MutMap</title>
            <link>http://www.medworm.com/index.php?rid=5674068&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FkmkxTE6d7Tk%2Fnbt.2095</link>
            <description>Authors: Akira Abe, Shunichi Kosugi, Kentaro Yoshida, Satoshi Natsume, Hiroki Takagi, Hiroyuki Kanzaki, Hideo Matsumura, Kakoto Yoshida, Chikako Mitsuoka, Muluneh Tamiru, Hideki Innan, Liliana Cano, Sophien Kamoun &amp; Ryohei Terauchi (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674068</comments>
            <pubDate>Sun, 22 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674068</guid>        </item>
        <item>
            <title>Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure</title>
            <link>http://www.medworm.com/index.php?rid=5674069&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FpxK3O9GW8Aw%2Fnbt.2089</link>
            <description>Authors: Suraj J Patel, Jack M Milwid, Kevin R King, Stefan Bohr, Arvin Iracheta-Velle, Matthew Li, Antonia Vitalo, Biju Parekkadan, Rohit Jindal &amp; Martin L Yarmush
Drug-induced liver injury (DILI) limits the development and application of many therapeutic compounds and presents major challenges to the pharmaceutical industry and clinical medicine. Acetaminophen-containing compounds are among the most frequently prescribed drugs and are also the most common cause of DILI. Here we describe a pharmacological strategy that targets gap junction communication to prevent amplification of fulminant hepatic failure and acetaminophen-induced hepatotoxicity. We demonstrate that connexin 32 (Cx32), a key hepatic gap junction protein, is an essential mediator of DILI by showing that mice deficient...</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674069</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674069</guid>        </item>
        <item>
            <title>Generation of human vascular smooth muscle subtypes provides insight into embryological origin–dependent disease susceptibility</title>
            <link>http://www.medworm.com/index.php?rid=5674067&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FaazbxiO_Cos%2Fnbt.2107</link>
            <description>Generation of human vascular smooth muscle subtypes provides insight into embryological origin&amp;#8211;dependent disease susceptibility

Nature Biotechnology 30, 165 (2012). 
      doi:10.1038/nbt.2107

Authors: Christine Cheung, Andreia S Bernardo, Matthew W B Trotter, Roger A Pedersen &amp; Sanjay Sinha (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674067</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674067</guid>        </item>
        <item>
            <title>Three-dimensional reconstruction of protein networks provides insight into human genetic disease</title>
            <link>http://www.medworm.com/index.php?rid=5674066&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FnXE92a79sZI%2Fnbt.2106</link>
            <description>Authors: Xiujuan Wang, Xiaomu Wei, Bram Thijssen, Jishnu Das, Steven M Lipkin &amp; Haiyuan Yu (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5674066</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5674066</guid>        </item>
        <item>
            <title>People</title>
            <link>http://www.medworm.com/index.php?rid=5576874&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FTX0Zkfem8Pc%2Fnbt.2097</link>
            <description>Nature Biotechnology 30, 116 (2012). 
      doi:10.1038/nbt.2097 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576874</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576874</guid>        </item>
        <item>
            <title>Broadening PhD curricula</title>
            <link>http://www.medworm.com/index.php?rid=5576873&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F6tx89WBE1vA%2Fnbt.2091</link>
            <description>Nature Biotechnology 30, 113 (2012). 
      doi:10.1038/nbt.2091

Author: Nathan L Vanderford
To provide formal education and training required for PhDs to perform their complex, multidisciplinary job functions, traditional PhD curricula should be restructured to include mandatory professional development course work. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576873</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576873</guid>        </item>
        <item>
            <title>Corrigendum: Drugmakers use real-world patient data to calibrate product development</title>
            <link>http://www.medworm.com/index.php?rid=5576872&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FVzIsND6OfYQ%2Fnbt0112-112f</link>
            <description>Nature Biotechnology 30, 112 (2012). 
      doi:10.1038/nbt0112-112f

Author: Cormac Sheridan (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576872</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576872</guid>        </item>
        <item>
            <title>Corrigendum: New models emerge for commercializing university assets</title>
            <link>http://www.medworm.com/index.php?rid=5576871&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FLFXYYutYKPE%2Fnbt0112-112e</link>
            <description>Nature Biotechnology 30, 112 (2012). 
      doi:10.1038/nbt0112-112e

Author: Nuala Moran (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576871</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576871</guid>        </item>
        <item>
            <title>Corrigendum: Biotechs follow big pharma lead back into academia</title>
            <link>http://www.medworm.com/index.php?rid=5576870&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Foly1AXLEVVI%2Fnbt0112-112d</link>
            <description>Nature Biotechnology 30, 112 (2012). 
      doi:10.1038/nbt0112-112d

Author: Jim Kling (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576870</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576870</guid>        </item>
        <item>
            <title>Erratum: Move over ZFNs</title>
            <link>http://www.medworm.com/index.php?rid=5576869&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FdT_3XuBEtQA%2Fnbt0112-112c</link>
            <description>Nature Biotechnology 30, 112 (2012). 
      doi:10.1038/nbt0112-112c

Author: Laura DeFrancesco (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576869</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576869</guid>        </item>
        <item>
            <title>Erratum: Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells</title>
            <link>http://www.medworm.com/index.php?rid=5576868&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FuLixrrk5_cE%2Fnbt0112-112b</link>
            <description>Authors: Kitai Kim, Rui Zhao, Akiko Doi, Kitwa Ng, Juli Unternaehrer, Patrick Cahan, Huo Hongguang, Yuin-Han Loh, Martin J Aryee, M William Lensch, Hu Li, James J Collins, Andrew P Feinberg &amp; George Q Daley (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576868</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576868</guid>        </item>
        <item>
            <title>Erratum: In defense of life sciences venture investing</title>
            <link>http://www.medworm.com/index.php?rid=5576867&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FpDeZ7TviHq8%2Fnbt0112-112a</link>
            <description>Authors: Bruce L Booth &amp; Bijan Salehizadeh (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576867</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576867</guid>        </item>
        <item>
            <title>The discovery and development of belimumab: the anti-BLyS–lupus connection</title>
            <link>http://www.medworm.com/index.php?rid=5576861&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FAwFjgtu693g%2Fnbt.2076</link>
            <description>The discovery and development of belimumab: the anti-BLyS&amp;#8211;lupus connection

Nature Biotechnology 30, 69 (2012). 
      doi:10.1038/nbt.2076

Authors: William Stohl &amp; David M Hilbert (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576861</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576861</guid>        </item>
        <item>
            <title>Natural products from symbionts</title>
            <link>http://www.medworm.com/index.php?rid=5576859&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FYrmfg2HmoLg%2Fnbt.2103</link>
            <description>Nature Biotechnology 30, 60 (2012). 
      doi:10.1038/nbt.2103

Author: Kathy Aschheim (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576859</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576859</guid>        </item>
        <item>
            <title>Clinical gene therapies progress</title>
            <link>http://www.medworm.com/index.php?rid=5576858&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fb_0f9JohRUQ%2Fnbt.2102</link>
            <description>Nature Biotechnology 30, 60 (2012). 
      doi:10.1038/nbt.2102

Author: Laura DeFrancesco (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576858</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576858</guid>        </item>
        <item>
            <title>Detection of beta cell death</title>
            <link>http://www.medworm.com/index.php?rid=5576857&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FaxbhxpEVWYY%2Fnbt.2101</link>
            <description>Nature Biotechnology 30, 60 (2012). 
      doi:10.1038/nbt.2101

Author: Markus Elsner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576857</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576857</guid>        </item>
        <item>
            <title>The strategizing of crowds</title>
            <link>http://www.medworm.com/index.php?rid=5576856&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FYHEGPSbpgig%2Fnbt.2100</link>
            <description>Nature Biotechnology 30, 60 (2012). 
      doi:10.1038/nbt.2100

Author: Markus Elsner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576856</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576856</guid>        </item>
        <item>
            <title>Pituitary in a dish</title>
            <link>http://www.medworm.com/index.php?rid=5576855&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FX-QCa6EBsCw%2Fnbt.2099</link>
            <description>Nature Biotechnology 30, 60 (2012). 
      doi:10.1038/nbt.2099

Author: Kathy Aschheim (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576855</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576855</guid>        </item>
        <item>
            <title>New competition in RNA regulation</title>
            <link>http://www.medworm.com/index.php?rid=5576854&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FnyT8WmsJ8z4%2Fnbt.2092</link>
            <description>Authors: Anastasia Khvorova &amp; Alexey Wolfson
An additional layer of RNA regulation in which RNAs encoded by genes and pseudogenes compete for microRNAs could offer new opportunities for oligonucleotide therapeutics. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576854</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576854</guid>        </item>
        <item>
            <title>Dopaminergic neurons for Parkinson's therapy</title>
            <link>http://www.medworm.com/index.php?rid=5576853&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fz4nsbNQmKGw%2Fnbt.2077</link>
            <description>Nature Biotechnology 30, 56 (2012). 
      doi:10.1038/nbt.2077

Author: Olle Lindvall
A differentiation protocol guided by developmental principles produces more-authentic dopaminergic neurons for transplantation in patients. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576853</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576853</guid>        </item>
        <item>
            <title>Parallel genome universes</title>
            <link>http://www.medworm.com/index.php?rid=5576852&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FkYw6zQwlZdA%2Fnbt.2085</link>
            <description>Nature Biotechnology 30, 55 (2012). 
      doi:10.1038/nbt.2085

Author: Tom Misteli
A new computational approach gives us the best chance at understanding how genomes are arranged in three-dimensional space and what that may mean for their function. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576852</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576852</guid>        </item>
        <item>
            <title>Recent patent applications related to gene and DNA synthesis</title>
            <link>http://www.medworm.com/index.php?rid=5576851&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F12a3FVia5fU%2Fnbt.2098</link>
            <description>Nature Biotechnology 30, 54 (2012). 
      doi:10.1038/nbt.2098 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576851</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576851</guid>        </item>
        <item>
            <title>Maintaining patents protecting biologics or small-molecule drugs</title>
            <link>http://www.medworm.com/index.php?rid=5576850&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FNF8KvbuyOds%2Fnbt.2082</link>
            <description>Authors: Ganesan Marimuthu, Sangita Kumari, Muthukrishnakumar Kandasamy, Srivatsan Raghunathan &amp; Gayatri Saberwal
A look at the maintenance rates of US patents protecting FDA-approved biologics and small molecules. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576850</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576850</guid>        </item>
        <item>
            <title>Reinventing clinical trials</title>
            <link>http://www.medworm.com/index.php?rid=5576849&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FV-Wo8Qg9IKc%2Fnbt.2083</link>
            <description>Nature Biotechnology 30, 41 (2012). 
      doi:10.1038/nbt.2083

Author: Malorye Allison
As R&amp;D costs spiral for drug developers, disruptive approaches to clinical trial design and management are gaining traction. Get ready for electronic data capture, precompetitive data sharing, virtual trials and a variety of bold new paradigms. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576849</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576849</guid>        </item>
        <item>
            <title>Factors influencing agbiotech adoption and development in sub-Saharan Africa</title>
            <link>http://www.medworm.com/index.php?rid=5576848&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FCG4lIgocEYw%2Fnbt.2088</link>
            <description>Authors: Obidimma C Ezezika, Abdallah S Daar, Kathryn Barber, Justin Mabeya, Fiona Thomas, Jennifer Deadman, Debbie Wang &amp; Peter A Singer (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576848</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576848</guid>        </item>
        <item>
            <title>European discussion forum on transgenic tree biosafety</title>
            <link>http://www.medworm.com/index.php?rid=5576847&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fj_xd0HsoOVI%2Fnbt.2078</link>
            <description>Authors: Matthias Fladung, Illimar Altosaar, Detlef Bartsch, Marie Baucher, Fabio Boscaleri, Fernando Gallardo, Hely H&amp;#228;ggman, Hans Hoenicka, Kaare Nielsen, Donatella Paffetti, Armand S&amp;#233;guin, Guenther Stotzky &amp; Cristina Vettori (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576847</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576847</guid>        </item>
        <item>
            <title>Exploiting host molecules to augment mycoinsecticide virulence</title>
            <link>http://www.medworm.com/index.php?rid=5576846&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FWQuU30Xolmg%2Fnbt.2080</link>
            <description>Authors: Yanhua Fan, Dov Borovsky, Chloe Hawkings, Almudena Ortiz-Urquiza &amp; Nemat O Keyhani (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576846</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576846</guid>        </item>
        <item>
            <title>Big data in small places</title>
            <link>http://www.medworm.com/index.php?rid=5576845&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fc2y07KRybkg%2Fnbt.2079</link>
            <description>Authors: Daniel MacLean &amp; Sophien Kamoun (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576845</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576845</guid>        </item>
        <item>
            <title>Bringing business risk into sharp focus</title>
            <link>http://www.medworm.com/index.php?rid=5576844&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FJd_WGysdcOo%2Fnbt.2081</link>
            <description>Authors: Bill Gruber &amp; Emily Walsh (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576844</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576844</guid>        </item>
        <item>
            <title>Approval on a knife edge</title>
            <link>http://www.medworm.com/index.php?rid=5576843&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F3ifAatf6EnQ%2Fnbt.2084</link>
            <description>Nature Biotechnology 30, 26 (2012). 
      doi:10.1038/nbt.2084

Author: Michael Eisenstein
In spite of its modest performance in clinical trials, Benlysta may offer effective relief against lupus. But physicians are still working to identify the right patients. Michael Eisenstein reports. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576843</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576843</guid>        </item>
        <item>
            <title>Building stem-cell genomics in California and beyond</title>
            <link>http://www.medworm.com/index.php?rid=5576842&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FxdQP7FwbLoU%2Fnbt.2086</link>
            <description>Authors: Natalie D DeWitt, Michael P Yaffe &amp; Alan Trounson
By devoting funding to whole-genome studies, such as epigenetic and copy-number variation in stem cells, research on new genomic technology, and standards for methodologies and data collection/sharing, CIRM can spur both basic and translational research. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576842</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576842</guid>        </item>
        <item>
            <title>The NIH's role in accelerating translational sciences</title>
            <link>http://www.medworm.com/index.php?rid=5576841&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FBoKTsWSRdK8%2Fnbt.2087</link>
            <description>Authors: John C Reed, E Lucile White, Jeffrey Aub&amp;#233;, Craig Lindsley, Min Li, Larry Sklar &amp; Stuart Schreiber
The NIH's proposed initiatives in translational science deserve solid financial backing from legislators and vocal support from the biomedical community. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576841</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576841</guid>        </item>
        <item>
            <title>Drug pipeline: Q411</title>
            <link>http://www.medworm.com/index.php?rid=5576840&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FWuzh4GrXD-g%2Fnbt.2090</link>
            <description>Nature Biotechnology 30, 15 (2012). 
      doi:10.1038/nbt.2090

Author: H Craig Mak (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576840</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576840</guid>        </item>
        <item>
            <title>Foundation Medicine</title>
            <link>http://www.medworm.com/index.php?rid=5576839&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F8DpHyX7Y8r8%2Fnbt0112-14</link>
            <description>Nature Biotechnology 30, 14 (2012). 
      doi:10.1038/nbt0112-14

Author: Michael Eisenstein
The Cambridge, Massachusetts&amp;#8211;based company plans to introduce next-generation gene sequencing into oncology practice and pathologists' laboratories. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576839</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576839</guid>        </item>
        <item>
            <title>Around the world in a month</title>
            <link>http://www.medworm.com/index.php?rid=5576838&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FYwHBQyX-Ukw%2Fnbt0112-13</link>
            <description>Nature Biotechnology 30, 13 (2012). 
      doi:10.1038/nbt0112-13 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576838</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576838</guid>        </item>
        <item>
            <title>Embryonic stem cell pioneer Geron exits field, cuts losses</title>
            <link>http://www.medworm.com/index.php?rid=5576837&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FIVBGyihJons%2Fnbt0112-12</link>
            <description>Nature Biotechnology 30, 12 (2012). 
      doi:10.1038/nbt0112-12

Author: Simon Frantz (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576837</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576837</guid>        </item>
        <item>
            <title>Monsanto to face biopiracy charges in India</title>
            <link>http://www.medworm.com/index.php?rid=5576836&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FVi9z3nLk0_A%2Fnbt0112-11</link>
            <description>Nature Biotechnology 30, 11 (2012). 
      doi:10.1038/nbt0112-11

Author: Lucas Laursen (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576836</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576836</guid>        </item>
        <item>
            <title>Russian fund steps up investments in innovative biotechs</title>
            <link>http://www.medworm.com/index.php?rid=5576835&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FSsdMxfkiYx0%2Fnbt0112-9a</link>
            <description>Nature Biotechnology 30, 9 (2012). 
      doi:10.1038/nbt0112-9a

Author: Alla Katsnelson (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576835</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576835</guid>        </item>
        <item>
            <title>Obama urges translation speed</title>
            <link>http://www.medworm.com/index.php?rid=5576834&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FJ117RzuCoxk%2Fnbt0112-9b</link>
            <description>Nature Biotechnology 30, 9 (2012). 
      doi:10.1038/nbt0112-9b

Author: Jeffrey L Fox (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576834</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576834</guid>        </item>
        <item>
            <title>$352 million into microRNA</title>
            <link>http://www.medworm.com/index.php?rid=5576833&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FP3VKgyK8_EY%2Fnbt0112-8b</link>
            <description>&amp;#36;352 million into microRNA

Nature Biotechnology 30, 8 (2012). 
      doi:10.1038/nbt0112-8b

Author: Sabine Lou&amp;#235;t (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576833</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576833</guid>        </item>
        <item>
            <title>Spinal device cancer risk</title>
            <link>http://www.medworm.com/index.php?rid=5576832&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FaxPrQcNmBBk%2Fnbt0112-8a</link>
            <description>Nature Biotechnology 30, 8 (2012). 
      doi:10.1038/nbt0112-8a

Author: Emily Waltz (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576832</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576832</guid>        </item>
        <item>
            <title>Safety profiles come to fore as more drugs approach MS market</title>
            <link>http://www.medworm.com/index.php?rid=5576831&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fi9_n_90rXjI%2Fnbt0112-6c</link>
            <description>Nature Biotechnology 30, 6 (2012). 
      doi:10.1038/nbt0112-6c

Author: Cormac Sheridan (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576831</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576831</guid>        </item>
        <item>
            <title>Pivotal FDA/Exelixis dispute</title>
            <link>http://www.medworm.com/index.php?rid=5576830&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FKFpZC4dHbIw%2Fnbt0112-6b</link>
            <description>Nature Biotechnology 30, 6 (2012). 
      doi:10.1038/nbt0112-6b

Author: Mark Ratner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576830</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576830</guid>        </item>
        <item>
            <title>Avastin loses breast cancer indication</title>
            <link>http://www.medworm.com/index.php?rid=5576829&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F61gNc39AVnU%2Fnbt0112-6a</link>
            <description>Nature Biotechnology 30, 6 (2012). 
      doi:10.1038/nbt0112-6a

Author: Karen Carey (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576829</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576829</guid>        </item>
        <item>
            <title>Eylea approval transforms Regeneron</title>
            <link>http://www.medworm.com/index.php?rid=5576828&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FWhBJz8kW8UY%2Fnbt0112-4</link>
            <description>Nature Biotechnology 30, 4 (2012). 
      doi:10.1038/nbt0112-4

Author: Mark Ratner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576828</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576828</guid>        </item>
        <item>
            <title>Incyte comes of age with JAK inhibitor approval</title>
            <link>http://www.medworm.com/index.php?rid=5576827&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FV5Ru-lADT5s%2Fnbt0112-3</link>
            <description>Nature Biotechnology 30, 3 (2012). 
      doi:10.1038/nbt0112-3

Author: Nuala Moran (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576827</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576827</guid>        </item>
        <item>
            <title>What happened to personalized medicine?</title>
            <link>http://www.medworm.com/index.php?rid=5576826&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Feq-gr6MnGA4%2Fnbt.2096</link>
            <description>Nature Biotechnology 30, 1 (2012). 
      doi:10.1038/nbt.2096

Personalized medicine falls a long way short of the predictive and preventative healthcare paradigm it once promised. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576826</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576826</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=5576825&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FAuGsFeYf7_M%2Fnbt.2104</link>
            <description>Nature Biotechnology 30, vii (2012). 
      doi:10.1038/nbt.2104 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576825</comments>
            <pubDate>Mon, 09 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576825</guid>        </item>
        <item>
            <title>Genome architectures revealed by tethered chromosome conformation capture and population-based modeling</title>
            <link>http://www.medworm.com/index.php?rid=5576864&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FG0kUGD1muus%2Fnbt.2057</link>
            <description>Authors: Reza Kalhor, Harianto Tjong, Nimanthi Jayathilaka, Frank Alber &amp; Lin Chen (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576864</comments>
            <pubDate>Sun, 25 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576864</guid>        </item>
        <item>
            <title>Performance comparison of whole-genome sequencing platforms</title>
            <link>http://www.medworm.com/index.php?rid=5576862&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fh45yPFmT_vA%2Fnbt.2065</link>
            <description>Authors: Hugo Y K Lam, Michael J Clark, Rui Chen, Rong Chen, Georges Natsoulis, Maeve O'Huallachain, Frederick E Dewey, Lukas Habegger, Euan A Ashley, Mark B Gerstein, Atul J Butte, Hanlee P Ji &amp; Michael Snyder (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576862</comments>
            <pubDate>Sun, 18 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576862</guid>        </item>
        <item>
            <title>Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing</title>
            <link>http://www.medworm.com/index.php?rid=5576860&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FXKg8u64DH6A%2Fnbt.2053</link>
            <description>Authors: Joke Reumers, Peter De Rijk, Hui Zhao, Anthony Liekens, Dominiek Smeets, John Cleary, Peter Van Loo, Maarten Van Den Bossche, Kirsten Catthoor, Bernard Sabbe, Evelyn Despierre, Ignace Vergote, Brian Hilbush, Diether Lambrechts &amp; Jurgen Del-Favero (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576860</comments>
            <pubDate>Sun, 18 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576860</guid>        </item>
        <item>
            <title>Resequencing 50 accessions of cultivated and wild rice yields markers for identifying agronomically important genes</title>
            <link>http://www.medworm.com/index.php?rid=5576866&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FrAuibBhBjkc%2Fnbt.2050</link>
            <description>Authors: Xun Xu, Xin Liu, Song Ge, Jeffrey D Jensen, Fengyi Hu, Xin Li, Yang Dong, Ryan N Gutenkunst, Lin Fang, Lei Huang, Jingxiang Li, Weiming He, Guojie Zhang, Xiaoming Zheng, Fumin Zhang, Yingrui Li, Chang Yu, Karsten Kristiansen, Xiuqing Zhang, Jian Wang, Mark Wright, Susan McCouch, Rasmus Nielsen, Jun Wang &amp; Wen Wang (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576866</comments>
            <pubDate>Sun, 11 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576866</guid>        </item>
        <item>
            <title>People</title>
            <link>http://www.medworm.com/index.php?rid=5492726&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FlFFNSB4ERao%2Fnbt.2067</link>
            <description>Nature Biotechnology 29, 1150 (2011). 
      doi:10.1038/nbt.2067 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492726</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492726</guid>        </item>
        <item>
            <title>The challenges of modern interdisciplinary medical research</title>
            <link>http://www.medworm.com/index.php?rid=5492725&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FH4D_oNaE058%2Fnbt.2062</link>
            <description>Authors: Philipp von Roth, Benedict J Canny, Hans-Dieter Volk, J Alison Noble, Charles G Prober, Carsten Perka &amp; Georg N Duda
The increasing complexity of medical science poses significant challenges to medical education, leading to a growing gap between medical researchers and treating practitioners. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492725</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492725</guid>        </item>
        <item>
            <title>New role for VEGF</title>
            <link>http://www.medworm.com/index.php?rid=5492717&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FiKpAYqlg4P0%2Fnbt.2073</link>
            <description>Nature Biotechnology 29, 1101 (2011). 
      doi:10.1038/nbt.2073

Author: Markus Elsner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492717</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492717</guid>        </item>
        <item>
            <title>Sifting proteins for proteomics</title>
            <link>http://www.medworm.com/index.php?rid=5492716&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fk0pojOkKbIM%2Fnbt.2072</link>
            <description>Nature Biotechnology 29, 1101 (2011). 
      doi:10.1038/nbt.2072

Author: Craig Mak (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492716</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492716</guid>        </item>
        <item>
            <title>Ribosomes reveal proteome complexity</title>
            <link>http://www.medworm.com/index.php?rid=5492715&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FUmR9gl77PGA%2Fnbt.2071</link>
            <description>Nature Biotechnology 29, 1101 (2011). 
      doi:10.1038/nbt.2071

Author: Markus Elsner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492715</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492715</guid>        </item>
        <item>
            <title>Multigenome analysis of variation</title>
            <link>http://www.medworm.com/index.php?rid=5492714&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fv5ZWrZmw6m8%2Fnbt.2070</link>
            <description>Nature Biotechnology 29, 1101 (2011). 
      doi:10.1038/nbt.2070

Author: Craig Mak (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492714</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492714</guid>        </item>
        <item>
            <title>Two antibodies for the price of one</title>
            <link>http://www.medworm.com/index.php?rid=5492713&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FeG09lviAJis%2Fnbt.2069</link>
            <description>Nature Biotechnology 29, 1101 (2011). 
      doi:10.1038/nbt.2069

Author: Laura DeFrancesco (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492713</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492713</guid>        </item>
        <item>
            <title>The new landscape of protein ubiquitination</title>
            <link>http://www.medworm.com/index.php?rid=5492712&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F-di7UmMwsyM%2Fnbt.2061</link>
            <description>Authors: Guoqiang Xu &amp; Samie R Jaffrey
Proteome-wide identification of ubiquitination events reveals their functional classes and identifies substrates for ubiquitin ligases. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492712</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492712</guid>        </item>
        <item>
            <title>Genomic rearrangement in three dimensions</title>
            <link>http://www.medworm.com/index.php?rid=5492711&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FTBtd1XUY_TQ%2Fnbt.2064</link>
            <description>Authors: PJ Hastings &amp; Susan M Rosenberg
Two studies illuminate why genome rearrangements in cancer cells occur where they do. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492711</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492711</guid>        </item>
        <item>
            <title>Dissecting cancer heterogeneity</title>
            <link>http://www.medworm.com/index.php?rid=5492710&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FzKmrdpsagMQ%2Fnbt.2063</link>
            <description>Authors: David Dornan &amp; Jeff Settleman
Transcriptional profiling of single cells in colon tumors may enable prediction of patient outcomes. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492710</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492710</guid>        </item>
        <item>
            <title>Recent patent applications related to agricultural microbes</title>
            <link>http://www.medworm.com/index.php?rid=5492709&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FvFjpBmRjjAo%2Fnbt.2066</link>
            <description>Nature Biotechnology 29, 1094 (2011). 
      doi:10.1038/nbt.2066 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492709</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492709</guid>        </item>
        <item>
            <title>Agricultural microbial resources: private property or global commons?</title>
            <link>http://www.medworm.com/index.php?rid=5492708&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FtlU8ni8uwcc%2Fnbt.2056</link>
            <description>Authors: David Kothamasi, Matthew Spurlock &amp; E Toby Kiers
Agricultural microbes have become an attractive target for patenting, but the lack of a consistent global patent regime and increasingly heated debates over microbial ownership rights are barriers to the development of this resource. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492708</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492708</guid>        </item>
        <item>
            <title>What's fueling the biotech engine—2010 to 2011</title>
            <link>http://www.medworm.com/index.php?rid=5492707&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fj8XN-VaTlEw%2Fnbt.2060</link>
            <description>What's fueling the biotech engine&amp;#8212;2010 to 2011

Nature Biotechnology 29, 1083 (2011). 
      doi:10.1038/nbt.2060

Author: Saurabh Aggarwal
In the past year, biologics sector sales grew by single digits, driven by monoclonal antibodies and insulin products. New product launches are showing mixed results and are facing rising challenges from changes to reimbursement policies. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492707</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492707</guid>        </item>
        <item>
            <title>Sarbanes-Oxley overburdens biotech companies</title>
            <link>http://www.medworm.com/index.php?rid=5492706&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FXc1JoAziS6M%2Fnbt.2059</link>
            <description>Nature Biotechnology 29, 1081 (2011). 
      doi:10.1038/nbt.2059

Author: Mark Kessel (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492706</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492706</guid>        </item>
        <item>
            <title>Access to human embryonic stem cell lines</title>
            <link>http://www.medworm.com/index.php?rid=5492705&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FYV70j8GdMlY%2Fnbt.2029</link>
            <description>Nature Biotechnology 29, 1079 (2011). 
      doi:10.1038/nbt.2029

Author: Aaron D Levine (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492705</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492705</guid>        </item>
        <item>
            <title>Re-evaluating PARP1 inhibitor in cancer</title>
            <link>http://www.medworm.com/index.php?rid=5492704&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FDBNMlZAiUHk%2Fnbt.2058</link>
            <description>Nature Biotechnology 29, 1078 (2011). 
      doi:10.1038/nbt.2058

Author: Alexei Tulin (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492704</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492704</guid>        </item>
        <item>
            <title>Relative potential of biosynthetic pathways for biofuels and bio-based products</title>
            <link>http://www.medworm.com/index.php?rid=5492703&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FkXDv2PVp_CQ%2Fnbt.2055</link>
            <description>Authors: Deepak Dugar &amp; Gregory Stephanopoulos (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492703</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492703</guid>        </item>
        <item>
            <title>Generation of the potent anti-malarial drug artemisinin in tobacco</title>
            <link>http://www.medworm.com/index.php?rid=5492702&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fi0651Th7_yk%2Fnbt.2054</link>
            <description>Authors: Moran Farhi, Elena Marhevka, Julius Ben-Ari, Anna Algamas-Dimantov, Zhuobin Liang, Vardit Zeevi, Orit Edelbaum, Ben Spitzer-Rimon, Hagai Abeliovich, Betty Schwartz, Tzvi Tzfira &amp; Alexander Vainstein (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492702</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492702</guid>        </item>
        <item>
            <title>Shape shifting</title>
            <link>http://www.medworm.com/index.php?rid=5492701&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F1f1McQfGuKI%2Fbioe.2011.10</link>
            <description>Nature Biotechnology 29, 1069 (2011). 
      doi:10.1038/bioe.2011.10

Author: Bob Baltera
Faced with limited funding and the need to find the most time- and cost-efficient route to proof of concept and relevance, how should you reorganize your company to facilitate development of your most valuable assets? (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492701</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492701</guid>        </item>
        <item>
            <title>Newsmaker: Zafgen</title>
            <link>http://www.medworm.com/index.php?rid=5492700&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FCsBo8xaT2kg%2Fnbt1211-1068</link>
            <description>Nature Biotechnology 29, 1068 (2011). 
      doi:10.1038/nbt1211-1068

Author: Jennifer Rohn
Zafgen hopes that small-molecule targeting of methionine aminopeptidase 2 (MetAP2), an enzyme originally associated with tumor angiogenesis, will lead to a new anti-obesity drug. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492700</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492700</guid>        </item>
        <item>
            <title>New startup models emerge as investor landscape shifts</title>
            <link>http://www.medworm.com/index.php?rid=5492699&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FSnhj7aN0bKA%2Fnbt1211-1066c</link>
            <description>Nature Biotechnology 29, 1066 (2011). 
      doi:10.1038/nbt1211-1066c

Author: Brady Huggett (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492699</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492699</guid>        </item>
        <item>
            <title>Near-record drug approvals</title>
            <link>http://www.medworm.com/index.php?rid=5492698&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FvNUpevSiBh8%2Fnbt1211-1066b</link>
            <description>Nature Biotechnology 29, 1066 (2011). 
      doi:10.1038/nbt1211-1066b

Author: Jeffrey L. Fox (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492698</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492698</guid>        </item>
        <item>
            <title>Jackson's $1.1 billion makeover</title>
            <link>http://www.medworm.com/index.php?rid=5492697&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FZ-QsTejVDHw%2Fnbt1211-1066a</link>
            <description>Jackson's &amp;#36;1.1 billion makeover

Nature Biotechnology 29, 1066 (2011). 
      doi:10.1038/nbt1211-1066a

Author: Jennifer Rohn (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492697</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492697</guid>        </item>
        <item>
            <title>Around the world in a month</title>
            <link>http://www.medworm.com/index.php?rid=5492696&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FPC700r7mlEY%2Fnbt1211-1065</link>
            <description>Nature Biotechnology 29, 1065 (2011). 
      doi:10.1038/nbt1211-1065 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492696</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492696</guid>        </item>
        <item>
            <title>Industry continues dabbling with open innovation models</title>
            <link>http://www.medworm.com/index.php?rid=5492695&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Ff5wNWaNY-8o%2Fnbt1211-1063a</link>
            <description>Nature Biotechnology 29, 1063 (2011). 
      doi:10.1038/nbt1211-1063a

Author: Cormac Sheridan (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492695</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492695</guid>        </item>
        <item>
            <title>Cold-tolerant trees win</title>
            <link>http://www.medworm.com/index.php?rid=5492694&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FWEzKnr1YToo%2Fnbt1211-1063b</link>
            <description>Nature Biotechnology 29, 1063 (2011). 
      doi:10.1038/nbt1211-1063b

Author: Emily Walt (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492694</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492694</guid>        </item>
        <item>
            <title>Interest groups jostle to influence PDUFA V</title>
            <link>http://www.medworm.com/index.php?rid=5492693&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FrtKjQ-XXqls%2Fnbt1211-1062</link>
            <description>Nature Biotechnology 29, 1062 (2011). 
      doi:10.1038/nbt1211-1062

Author: Jeffrey L Fox (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492693</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492693</guid>        </item>
        <item>
            <title>GlaxoSmithKline malaria vaccine phase 3 trial heralded</title>
            <link>http://www.medworm.com/index.php?rid=5492692&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F66ezZ6pggFg%2Fnbt1211-1060b</link>
            <description>Nature Biotechnology 29, 1060 (2011). 
      doi:10.1038/nbt1211-1060b

Author: Simon Franz (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492692</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492692</guid>        </item>
        <item>
            <title>Shutdown by auction</title>
            <link>http://www.medworm.com/index.php?rid=5492691&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FEqy2zuszWM8%2Fnbt1211-1060a</link>
            <description>Nature Biotechnology 29, 1060 (2011). 
      doi:10.1038/nbt1211-1060a

Author: Brian Orelli (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492691</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492691</guid>        </item>
        <item>
            <title>Conflicts of interest go online</title>
            <link>http://www.medworm.com/index.php?rid=5492690&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FwjmN6EsI03Y%2Fnbt1211-1058</link>
            <description>Nature Biotechnology 29, 1058 (2011). 
      doi:10.1038/nbt1211-1058

Author: Gunjan Sinha (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492690</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492690</guid>        </item>
        <item>
            <title>European court bans embryonic stem cell patents</title>
            <link>http://www.medworm.com/index.php?rid=5492689&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F7vFGfVbn-Hg%2Fnbt1211-1057</link>
            <description>Nature Biotechnology 29, 1057 (2011). 
      doi:10.1038/nbt1211-1057

Author: Nuala Moran (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492689</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492689</guid>        </item>
        <item>
            <title>Tilting toward secrecy</title>
            <link>http://www.medworm.com/index.php?rid=5492688&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FSv0GuKnIElE%2Fnbt.2075</link>
            <description>Nature Biotechnology 29, 1055 (2011). 
      doi:10.1038/nbt.2075

A European high court ruling on the patentability of inventions related to human embryonic stem cells could promote secrecy and reduce access to data and cell lines. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492688</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492688</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=5492687&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FHrZrtCAJzPY%2Fnbt.2068</link>
            <description>Nature Biotechnology 29, vii (2011). 
      doi:10.1038/nbt.2068 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492687</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492687</guid>        </item>
        <item>
            <title>Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage</title>
            <link>http://www.medworm.com/index.php?rid=5492724&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FILRkrJl8DD0%2Fnbt.2051</link>
            <description>Authors: Katherine Amps, Peter W Andrews, George Anyfantis, Lyle Armstrong, Stuart Avery, Hossein Baharvand, Julie Baker, Duncan Baker, Maria B Munoz, Stephen Beil, Nissim Benvenisty, Dalit Ben-Yosef, Juan-Carlos Biancotti, Alexis Bosman, Romulo Martin Brena, Daniel Brison, Gunilla Caisander, Mar&amp;#237;a V Camarasa, Jieming Chen, Eric Chiao, Young Min Choi, Andre B H Choo, Daniel Collins, Alan Colman, Jeremy M Crook, George Q Daley, Anne Dalton, Paul A De Sousa, Chris Denning, Janet Downie, Petr Dvorak, Karen D Montgomery, Anis Feki, Angela Ford, Victoria Fox, Ana M Fraga, Tzvia Frumkin, Lin Ge, Paul J Gokhale, Tamar Golan-Lev, Hamid Gourabi, Michal Gropp, Lu Guangxiu, Ales Hampl, Katie Harron, Lyn Healy, Wishva Herath, Frida Holm, Outi Hovatta, Johan Hyllner, Maneesha S Inamdar, Astrid Kre...</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492724</comments>
            <pubDate>Sun, 27 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492724</guid>        </item>
        <item>
            <title>Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells</title>
            <link>http://www.medworm.com/index.php?rid=5492721&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FLnmySnVwrMQ%2Fnbt.2052</link>
            <description>Authors: Kitai Kim, Rui Zhao, Akiko Doi, Kitwa Ng, Juli Unternaehrer, Patrick Cahan, Huo Hongguang, Yuin-Han Loh, Martin J Aryee, M William Lensch, Hu Li, James J Collins, Andrew P Feinberg &amp; George Q Daley (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492721</comments>
            <pubDate>Sun, 27 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492721</guid>        </item>
        <item>
            <title>High order chromatin architecture shapes the landscape of chromosomal alterations in cancer</title>
            <link>http://www.medworm.com/index.php?rid=5492719&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FPuzaS1rzKY8%2Fnbt.2049</link>
            <description>Authors: Geoff Fudenberg, Gad Getz, Matthew Meyerson &amp; Leonid A Mirny (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492719</comments>
            <pubDate>Sun, 20 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492719</guid>        </item>
        <item>
            <title>DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes</title>
            <link>http://www.medworm.com/index.php?rid=5492718&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fx-LflQaZh-U%2Fnbt.2030</link>
            <description>Authors: Subhajyoti De &amp; Franziska Michor (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492718</comments>
            <pubDate>Sun, 20 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492718</guid>        </item>
        <item>
            <title>Targeted RNA sequencing reveals the deep complexity of the human transcriptome</title>
            <link>http://www.medworm.com/index.php?rid=5576865&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FOY1k3LTEahE%2Fnbt.2024</link>
            <description>Authors: Tim R Mercer, Daniel J Gerhardt, Marcel E Dinger, Joanna Crawford, Cole Trapnell, Jeffrey A Jeddeloh, John S Mattick &amp; John L Rinn
Transcriptomic analyses have revealed an unexpected complexity to the human transcriptome, whose breadth and depth exceeds current RNA sequencing capability. Using tiling arrays to target and sequence select portions of the transcriptome, we identify and characterize unannotated transcripts whose rare or transient expression is below the detection limits of conventional sequencing approaches. We use the unprecedented depth of coverage afforded by this technique to reach the deepest limits of the human transcriptome, exposing widespread, regulated and remarkably complex noncoding transcription in intergenic regions, as well as unannotated exons and ...</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576865</comments>
            <pubDate>Sun, 13 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5576865</guid>        </item>
        <item>
            <title>Single-cell dissection of transcriptional heterogeneity in human colon tumors</title>
            <link>http://www.medworm.com/index.php?rid=5492722&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Flc8m2XN95vE%2Fnbt.2038</link>
            <description>Authors: Piero Dalerba, Tomer Kalisky, Debashis Sahoo, Pradeep S Rajendran, Michael E Rothenberg, Anne A Leyrat, Sopheak Sim, Jennifer Okamoto, Darius M Johnston, Dalong Qian, Maider Zabala, Janet Bueno, Norma F Neff, Jianbin Wang, Andrew A Shelton, Brendan Visser, Shigeo Hisamori, Yohei Shimono, Marc van de Wetering, Hans Clevers, Michael F Clarke &amp; Stephen R Quake (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492722</comments>
            <pubDate>Sun, 13 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5492722</guid>        </item>
        <item>
            <title>People</title>
            <link>http://www.medworm.com/index.php?rid=5396984&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F8ddZUre6nZQ%2Fnbt.2045</link>
            <description>Nature Biotechnology 29, 1054 (2011). 
      doi:10.1038/nbt.2045 (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396984</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396984</guid>        </item>
        <item>
            <title>Third-quarter biotech job picture</title>
            <link>http://www.medworm.com/index.php?rid=5396983&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FBkNxkqCXV64%2Fnbt.2037</link>
            <description>Nature Biotechnology 29, 1052 (2011). 
      doi:10.1038/nbt.2037

Author: Michael Francisco (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396983</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396983</guid>        </item>
        <item>
            <title>Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus</title>
            <link>http://www.medworm.com/index.php?rid=5396974&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FVfvVXtyN-rg%2Fnbt.2020</link>
            <description>Authors: Ann D Kwong, Robert S Kauffman, Patricia Hurter &amp; Peter Mueller (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396974</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396974</guid>        </item>
        <item>
            <title>How to apply de Bruijn graphs to genome assembly</title>
            <link>http://www.medworm.com/index.php?rid=5396973&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F_DMNdW8GGVs%2Fnbt.2023</link>
            <description>Authors: Phillip E C Compeau, Pavel A Pevzner &amp; Glenn Tesler
A mathematical concept known as a de Bruijn graph turns the formidable challenge of assembling a contiguous genome from billions of short sequencing reads into a tractable computational problem. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396973</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396973</guid>        </item>
        <item>
            <title>Toward human therapeutic cloning</title>
            <link>http://www.medworm.com/index.php?rid=5396972&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FKbiJrSQsd68%2Fnbt.2044</link>
            <description>Nature Biotechnology 29, 986 (2011). 
      doi:10.1038/nbt.2044

Author: Kathy Aschheim (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396972</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396972</guid>        </item>
        <item>
            <title>Sequencing translocations</title>
            <link>http://www.medworm.com/index.php?rid=5396971&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FW9bglLg_pJI%2Fnbt.2043</link>
            <description>Nature Biotechnology 29, 986 (2011). 
      doi:10.1038/nbt.2043

Author: Markus Elsner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396971</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396971</guid>        </item>
        <item>
            <title>Nanopores quantify miRNAs</title>
            <link>http://www.medworm.com/index.php?rid=5396970&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FwhKZSXlGo5M%2Fnbt.2042</link>
            <description>Nature Biotechnology 29, 986 (2011). 
      doi:10.1038/nbt.2042

Author: Markus Elsner (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396970</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396970</guid>        </item>
        <item>
            <title>Antibody clamps phosphatase inactive</title>
            <link>http://www.medworm.com/index.php?rid=5396969&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F-qPPaJuoSAw%2Fnbt.2041</link>
            <description>Nature Biotechnology 29, 986 (2011). 
      doi:10.1038/nbt.2041

Author: Craig Mak (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396969</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396969</guid>        </item>
        <item>
            <title>Hepatocytes go neuronal</title>
            <link>http://www.medworm.com/index.php?rid=5396968&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FRpi7HOqgPQQ%2Fnbt.2040</link>
            <description>Nature Biotechnology 29, 986 (2011). 
      doi:10.1038/nbt.2040

Author: Laura DeFrancesco (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396968</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396968</guid>        </item>
        <item>
            <title>Road test for genetically modified mosquitoes</title>
            <link>http://www.medworm.com/index.php?rid=5396967&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FZBZJLIczidE%2Fnbt.2025</link>
            <description>Authors: Todd Shelly &amp; Don McInnis
Results from the first open-field trial of transgenic mosquitoes bode well for large-scale releases to fight infectious diseases. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396967</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396967</guid>        </item>
        <item>
            <title>Primate genomes for biomedicine</title>
            <link>http://www.medworm.com/index.php?rid=5396966&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FZFKC-wanBdg%2Fnbt.2032</link>
            <description>Authors: Steven E Bosinger, Zachary P Johnson &amp; Guido Silvestri
Genome sequences are now available for two macaque species used in infectious disease research and drug safety testing. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396966</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396966</guid>        </item>
        <item>
            <title>Interrogating the kinome</title>
            <link>http://www.medworm.com/index.php?rid=5396965&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2F2ZkYezmiRHY%2Fnbt.2021</link>
            <description>Authors: Chao Zhang, Gaston Habets &amp; Gideon Bollag
Comprehensive studies of the kinome set the stage for discovering the next generation of kinase-directed drugs. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396965</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396965</guid>        </item>
        <item>
            <title>Recent patent applications in antibody fragments: an academic update from the EU</title>
            <link>http://www.medworm.com/index.php?rid=5396964&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FHtANVK2-Uz8%2Fnbt.2039</link>
            <description>Nature Biotechnology 29, 979 (2011). 
      doi:10.1038/nbt.2039

Author: Julien Muzard (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396964</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396964</guid>        </item>
        <item>
            <title>Theory of knowledge and biotech patents: worlds apart?</title>
            <link>http://www.medworm.com/index.php?rid=5396963&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fi43aVTbybtQ%2Fnbt.2026</link>
            <description>Authors: Myriam M Altamirano-Bustamante, Adalberto de Hoyos &amp; Le&amp;#243;n Oliv&amp;#233;
The development of original research requires tacit as well as explicit knowledge, which allows for the establishment of new epistemic trajectories with novel epistemic horizons. Much of the tacit knowledge involved in the innovation process can be transmitted as explicit knowledge through the patent document. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396963</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396963</guid>        </item>
        <item>
            <title>Going viral</title>
            <link>http://www.medworm.com/index.php?rid=5396962&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FEO5MAapVmqE%2Fnbt.2033</link>
            <description>Authors: Victor Bethencourt &amp; Christopher Scott
Affymetrix was an early mover in the DNA microarray space that came to dominate the market, overcoming criticism from its users and a slew of cutthroat competitors. How did it do it? (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396962</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396962</guid>        </item>
        <item>
            <title>Harnessing cloud computing with Galaxy Cloud</title>
            <link>http://www.medworm.com/index.php?rid=5396961&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2Fn0W1_mn8060%2Fnbt.2028</link>
            <description>Authors: Enis Afgan, Dannon Baker, Nate Coraor, Hiroki Goto, Ian M Paul, Kateryna D Makova, Anton Nekrutenko &amp; James Taylor (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396961</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396961</guid>        </item>
        <item>
            <title>A label we don't need</title>
            <link>http://www.medworm.com/index.php?rid=5396960&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FORa1kfbRSoI%2Fnbt.2027</link>
            <description>Authors: Henry I Miller &amp; Drew L Kershen (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396960</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396960</guid>        </item>
        <item>
            <title>Hepatitis C: move over interferon</title>
            <link>http://www.medworm.com/index.php?rid=5396958&amp;cid=s_32086_70_f&amp;fid=32086&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fnbt%2Frss%2Fcurrent%2F%7E3%2FwV8Al__gHZc%2Fnbt.2031</link>
            <description>Nature Biotechnology 29, 963 (2011). 
      doi:10.1038/nbt.2031

Author: Ken Garber
Following approval of hepatitis C virus protease inhibitors Incivek and Victrelis, companies are partnering to devise all-oral combination antiviral regimens without interferon &amp;#945;. But the virus is a long way from vanquished. Ken Garber investigates. (Source: Nature Biotechnology)</description>
            <author>Nature Biotechnology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396958</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5396958</guid>        </item>
    </channel>
</rss>

